SO BASICALLY LOW AND MIDDLE INCOME COUNTRIES COULD BE PRODUCING VACCINES AND TREATMENTS FOR THEMSELVES BUT INTELLECTUAL PROPERTY RULES GIVE BIG PHARMACEUTICAL COMPANIES A MONOPOLY ON LIFESAVING TOOLS THAT WERE LARGELY DEVELOPED WITH PUBLIC FUNDING